Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-562

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 63323-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Biv07 0000 01

Chemical structure diagram of Bivalirudin, depicting its molecular formula with atoms and bonds, including functional groups and peptide linkages. The structure includes a note indicating a variable group with x ranging from 1.0 to 2.2.*

FDA Label Image

Biv07 0000 02

FDA Label Image

Biv07 0000 03

Bivalirudin 250 mg per vial injection powder label for intravenous use. The label specifies the product is for single-dose use only and instructs discarding any unused portion. It is labeled by Fresenius Kabi USA, LLC with NDC 63323-562-41.*

FDA Label Image

Biv07 0000 04

Bivalirudin 250 mg per vial injection powder, lyophilized, for intravenous use. The label specifies 10 single-dose vials with instructions to discard unused portions. The product is labeled by Fresenius Kabi USA, LLC under NDC 63323-562-15 and marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.